Cue Biopharma (CUE) Enterprise Value (2017 - 2025)
Cue Biopharma recorded quarterly Enterprise Value of -$27.7 million in Q4 2025, down 52.16% quarter-over-quarter from -$18.2 million in Q3 2025, and down 18.41% year-over-year from -$33.9 million in Q4 2024.
Cue Biopharma's Enterprise Value history runs 9 years deep, the most recent figure standing at -$27.7 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 18.41% year-over-year to -$27.7 million; the TTM figure through Dec 2025 stood at -$27.7 million (down 18.41% YoY), while the FY2025 annual figure was -$27.7 million, down 18.41% from the prior year.
- Enterprise Value came in at -$27.7 million for Q4 2025 at Cue Biopharma, down from -$18.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$14.0 million in Q1 2025 to a low of -$76.3 million in Q4 2022.
- A 5-year average of -$48.9 million and a median of -$53.4 million in 2021 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 50.33% in 2021 and soared 65.76% in 2025, its largest moves.
- Cue Biopharma's Enterprise Value stood at -$52.2 million in 2021, then slumped by 46.12% to -$76.3 million in 2022, then jumped by 36.03% to -$48.8 million in 2023, then jumped by 52.07% to -$23.4 million in 2024, then dropped by 18.41% to -$27.7 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$27.7 million, -$18.2 million, and -$28.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Cue Biopharma | 449.73 Mn | 422.04 Mn | - | -27.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.69 Mn |
| Sep 30, 2025 | -18.20 Mn |
| Jun 30, 2025 | -27.96 Mn |
| Mar 31, 2025 | -14.05 Mn |
| Dec 31, 2024 | -23.39 Mn |
| Sep 30, 2024 | -32.42 Mn |
| Jun 30, 2024 | -30.03 Mn |
| Mar 31, 2024 | -41.03 Mn |
| Dec 31, 2023 | -48.80 Mn |
| Sep 30, 2023 | -54.69 Mn |
| Jun 30, 2023 | -57.89 Mn |
| Mar 31, 2023 | -66.20 Mn |
| Dec 31, 2022 | -76.29 Mn |
| Sep 30, 2022 | -59.18 Mn |
| Jun 30, 2022 | -66.13 Mn |
| Mar 31, 2022 | -67.93 Mn |
| Dec 31, 2021 | -52.21 Mn |
| Sep 30, 2021 | -67.63 Mn |
| Jun 30, 2021 | -73.92 Mn |
| Mar 31, 2021 | -73.26 Mn |
| Dec 31, 2020 | -84.87 Mn |
| Sep 30, 2020 | -91.80 Mn |
| Mar 31, 2020 | -48.73 Mn |
| Dec 31, 2019 | -59.41 Mn |
| Sep 30, 2019 | -31.38 Mn |
| Jun 30, 2019 | -28.26 Mn |
| Mar 31, 2019 | -21.96 Mn |
| Dec 31, 2018 | -39.21 Mn |
| Sep 30, 2018 | -39.18 Mn |
| Jun 30, 2018 | -45.79 Mn |
| Mar 31, 2018 | -53.15 Mn |
| Dec 31, 2017 | -63.58 Mn |
| Sep 30, 2017 | -3.40 Mn |
| Jun 30, 2017 | -7.36 Mn |
| Mar 31, 2017 | -10.91 Mn |